Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial.

M K Wallack; M Sivanandham; K Ditaranto; P Shaw; C M Balch; M M Urist; K I Bland; D Murray; W A Robinson; L Flaherty

doi:10.1097/00000658-199708000-00012

Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial.

Identifier:nobleid.org/w1/20260515/6DBFCC0D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/6DBFCC0D.svg?ark=w1%2F20260515%2F6DBFCC0D)](https://nobleid.org/work/w1/20260515/6DBFCC0D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial.

Identifier:nobleid.org/w1/20260515/6DBFCC0D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/6DBFCC0D.svg?ark=w1%2F20260515%2F6DBFCC0D)](https://nobleid.org/work/w1/20260515/6DBFCC0D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work